Drug treatment involvement in GI symptoms developed during hospitalisation
| Antibiotic treatment | Non-antibiotic treatment | P value | |
| Diarrhoea | 17/90 (18.9) | 1/90 (1.1) | 0.034 |
| Non-diarrhoea | 49/90 (54.4) | 23/90 (25.6) | |
| Anorexia | 11/90 (12.2) | 1/90 (1.1) | 0.17 |
| Non-anorexia | 54/90 (60.0) | 24/90 (26.7) | |
| Nausea | 12/92 (13.0) | 2/92 (2.2) | 0.33 |
| Non-nausea | 54/92 (58.7) | 24/92 (26.1) | |
| Vomiting | 3/95 (3.2) | 1/95 (1.1) | 1.00 |
| Non-vomiting | 66/95 (69.5) | 25/95 (26.3) | |
| Increased bilirubin | 20/95 (21.1) | 2/95 (2.1) | 0.028 |
| Normal bilirubin | 49/95 (51.6) | 24/95 (25.3) |
| Antiviral treatment | Non-antiviral treatment | P value | |
| Diarrhoea | 18/90 (20.0) | 0 | 0.34 |
| Non-diarrhoea | 66/90 (73.3) | 6/90 (6.7) | |
| Anorexia | 12/90 (13.3) | 0 | 1.00 |
| Non-anorexia | 72/90 (80.0) | 6/90 (6.7) | |
| Nausea | 14/92 (15.2) | 0 | 0.59 |
| Non-nausea | 72/92 (78.3) | 6/92 (6.5) | |
| Vomiting | 4/95 (4.2) | 0 | 1.00 |
| Non-vomiting | 85/95 (89.5) | 6/95 (6.3) | |
| Increased bilirubin | 22/95 (23.2) | 0 | 0.33 |
| Normal bilirubin | 67/95 (70.5) | 6/95 (6.3) |
Data are presented as n/N (%). N is the total number of patients except for those who have related GI symptoms on initial presentation.